Photosensitizing Antihypertensive Meds Up Risk of Lip Cancer

Share this article:
Photosensitizing Antihypertensive Meds Up Risk of Lip Cancer
Photosensitizing Antihypertensive Meds Up Risk of Lip Cancer

(HealthDay News) – For non-Hispanic whites, long-term treatment with photosensitizing antihypertensive agents correlates with an increased likelihood of lip cancer, according to a study published online Aug 6 in the Archives of Internal Medicine.

Gary D Friedman, MD, from the Kaiser Permanente Medical Care Program in Oakland, CA, and colleagues characterized the risk of lip cancer associated with commonly used antihypertensive drugs that cause photosensitivity. Prescriptions dispensed and cancer occurrence was ascertained from a comprehensive medical care program from August 1994–February 2008. A total of 712 patients with lip cancer were identified and matched by age, gender, and cohort year to 22,904 controls among non-Hispanic whites. The impact of use of diuretics, hydrochlorothiazide (HCTZ) and HCTZ combined with triamterene (HCTZ/TR), lisinopril, nifedipine, and the non-photosensitizer atenolol for at least two years before diagnosis was determined.

The researchers found that, compared with no use, the likelihood of lip cancer was increased with at least a five-year supply of HCTZ (odds ratio [OR], 4.22); HCTZ/TR (OR, 2.82); lisinopril (OR, 1.42; 95% confidence interval, 0.95–2.13); nifedipine (OR, 2.5); and atenolol (OR, 1.93). The OR for atenolol was reduced to 0.54 when the other drugs were excluded.

"Lip cancer remains rare and an increased risk of developing it is generally outweighed by the benefits of these blood pressure drugs and other photosensitizing medications," Friedman said in a statement. "Physicians prescribing photosensitizing drugs should ascertain whether patients are at high risk of lip cancer by virtue of fair skin and long-term sun exposure and discuss lip protection with them."

Several authors disclosed financial ties to the pharmaceutical and legal industries.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs